News

Clínic Barcelona

Research November 15 2022

Eight researchers from the Hospital Clínic-IDIBAPS and the University of Barcelona in the ranking of the best in the world

The list, published by Clarivate Analytics, identifies the most influential experts, who are among the 1% most highly cited in their speciality in di1

Clínic Barcelona

Research October 4 2022

Researchers describe a genetic signature that predicts the response to immunotherapy treatment in liver cancer

In an important breakthrough in precision medicine and for the approval of cost-effective treatments, the expression of eleven genes is found to make1

Clínic Barcelona

Research May 31 2022

How have treatments for hepatocellular carcinoma improved?

Researchers at the Hospital Clínic-IDIBAPS and the University of Barcelona have published a review article in the journal Nature Cancer in which they1

Clínic Barcelona

Research December 28 2021

The role of immunotherapy in hepatocellular carcinoma

Immunotherapy has revolutionized the treatment of hepatocellular carcinoma. Researchers from the Hospital Clínic-IDIBAPS have published a review in t1

Clínic Barcelona

Research September 17 2021

A meta-analysis of phase-III trials shows that immunotherapy is more efficacious in liver cancer of viral origin than of nonviral origin

Researchers at IDIBAPS have led a study, published in the journal Gastroenterology, in which they analyzed the clinical trials published in the past1

4 5

page1
page2
page3
page4 , current page.
page5

News

Eight researchers from the Hospital Clínic-IDIBAPS and the University of Barcelona in the ranking of the best in the world

Researchers describe a genetic signature that predicts the response to immunotherapy treatment in liver cancer

How have treatments for hepatocellular carcinoma improved?

The role of immunotherapy in hepatocellular carcinoma

A meta-analysis of phase-III trials shows that immunotherapy is more efficacious in liver cancer of viral origin than of nonviral origin

navigation between pages below